Position in JNJ
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$3,554,310
+$272,703 QoQ
Shares Held
13,995
+4.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#1,873
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pekin Hardy Strauss, Inc. holds $25,845,902 across 12 Drug Manufacturers - General names. JNJ ranks #3 (13.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
28,681 | $7,217,286 | |
| 2 | NVS |
Novartis AG
|
26,136 | $4,096,033 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
13,995 | $3,554,310 | |
| 4 | NVO |
Novo Nordisk A S
|
70,160 | $3,363,470 | |
| 5 | MRK |
Merck & Co., Inc.
|
24,621 | $3,163,798 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
23,721 | $1,366,804 | |
| 7 | LLY |
ELI LILLY & Co
|
971 | $1,164,646 | |
| 8 | AZN |
Astrazeneca PLC
|
3,262 | $618,540 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,554,310 | 13,995 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $3,281,607 | 13,425 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3,157,643 | 15,258 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $2,704,350 | 14,585 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,423,989 | 15,869 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $3,493,917 | 21,068 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $3,422,287 | 23,664 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $4,254,561 | 26,253 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,914,310 | 26,781 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $4,307,988 | 27,233 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $4,345,146 | 27,722 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $4,621,258 | 29,671 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $5,025,683 | 30,363 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $4,779,735 | 30,837 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $5,507,417 | 31,177 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,187,823 | 31,757 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $5,697,715 | 32,098 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $5,715,135 | 32,247 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,536,167 | 32,362 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $5,282,826 | 32,711 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,396,882 | 32,760 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $6,026,221 | 36,667 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $5,903,009 | 37,508 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $5,431,291 | 36,481 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $4,803,358 | 34,156 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $4,412,262 | 33,648 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||